查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1758043

医疗保健领域区块链的全球市场

Blockchain in Healthcare
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 216 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球医疗保健区块链市场规模将达到 130 亿美元

全球医疗保健区块链市场规模预计在2024年为12亿美元，预计到2030年将达到130亿美元，2024年至2030年的复合年增长率为49.0%。作为报告分析的细分市场之一，私有网路预计将实现51.8%的复合年增长率，并在分析期结束时达到104亿美元。公共网路细分市场在分析期间内的复合年增长率预计为40.4%。

美国市场规模估计为 3.122 亿美元，中国市场预计复合年增长率为 46.2%

美国医疗保健区块链市场规模预计在2024年达到3.122亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到19亿美元，在2024-2030年的分析期间内，复合年增长率为46.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为44.9%和41.9%。在欧洲，预计德国的复合年增长率约为33.2%。

全球医疗保健市场区块链—主要趋势和驱动因素摘要

为什么区块链会成为医疗保健创新的基础技术？

区块链技术正迅速成为医疗保健领域的一股变革力量，有望解决医疗保健产业一些最持久的挑战，包括资料碎片化、安全漏洞和管理流程低效。区块链的核心在于提供一个去中心化、不可篡改的帐本，使不同的医疗保健相关人员能够安全透明地共用资料。在病历、保险理赔、临床试验和供应链资料通常各自为政、难以核对的环境下，这种独特的能力尤其重要。透过实现对防篡改资讯的即时访问，区块链提高了资料完整性，并促进了传统上无法无缝整合的系统之间的互通性。处理电子健康记录(EHR) 时对网路安全和隐私日益增长的需求也是一个主要驱动因素，而区块链提供的端对端加密和检验的存取控制超越了现有标准。随着数位医疗服务透过远端医疗、穿戴式装置和健康应用程式不断发展，区块链提供了一种解决方案，可以管理跨装置生成和共用的敏感健康数据的激增。此外，政府和监管机构越来越意识到这项技术的潜力，全球范围内启动了试验计画和官民合作关係关係，以测试基于区块链的医疗记录管理、药物可追溯性和同意处理应用。随着信任和透明度成为医疗保健转型的关键支柱，区块链不仅仅是一种 IT 增强，而且是医疗保健服务新时代的根本推动者。

区块链应用在不同医疗保健领域如何发展？

区块链在医疗保健领域的应用范围正在迅速扩展，其应用涵盖多个领域，包括病患资料管理、药品供应链、临床试验、保险和医疗服务提供者资格认证。在病历领域，区块链有助于创建由患者拥有和控制的纵向健康记录，并可安全地与多家医疗服务提供者共用。这在跨专科和跨地区的慢性病管理和护理协调中尤其重要。在製药业，区块链正被用于打击假药，实现药品从製造商到药房的端到端可追溯性。这种透明度确保了药品的真实性，减少了欺诈，并提高了药品召回的效率。同样，区块链透过为方案、患者知情同意书和检测结果提供不可篡改的时间戳数据，提高了临床试验的完整性。在保险业，智慧合约正在简化理赔流程，实现核准和支付的自动化，同时降低诈欺和管理成本。同时，医疗保健机构开始使用区块链即时检验医疗服务提供者的资格和执照，从而加快招聘速度并提高员工流动性。这些应用不仅提高了效率，也重塑了整个医疗生态系统中信任的建立和维护方式。随着越来越多的医疗机构采用可互通的区块链平台，该技术将从小众使用案例发展到企业级集成，预示着一个更具协作性、以患者为中心、资料安全的未来。

监管框架和产业合作将如何影响区块链的采用？

区块链在医疗保健领域的应用将深受法律规范、跨部门协作以及实现互通性和信任的技术标准的建立的影响。作为一个受到严格监管的行业，医疗保健必须确保区块链的实施符合严格的法律要求，例如美国的《健康保险流通与责任法》(HIPAA)、欧洲的《一般资料保护规范》(GDPR) 以及其他地区的资料保护法。遵守这些法规需要精心设计区块链架构，以支援隐私设计、选择性资料存取和被遗忘权等功能。为了克服这些复杂性，像突触健康联盟(Synaptic Health 休閒) 和 Mediledger计划这样的产业联盟正在兴起，它们将保险公司、医疗服务提供者、科技公司和监管机构聚集在一起，共同开发符合合规标准并最大限度促进创新的区块链框架。协作对于创建通用的资料交换和系统互通性通讯协定也至关重要，而这一直是大规模部署的主要障碍。 HL7 和 IEEE 等标准开发组织正在努力将区块链纳入现有的医疗保健互通性框架，例如 FHIR（快速医疗保健互通性资源）。政府资助和沙盒计画正在进一步加速区块链在医疗保健领域的实验，有助于降低风险并检验投资报酬率。跨竞争边界的相关人员参与将在区块链从试点阶段快速迈向广泛应用方面发挥关键作用。在此背景下，监管透明度、相关人员协作以及扩充性的技术标准正成为决定区块链融入主流医疗保健业务的速度和范围的关键推动因素。

推动医疗保健市场区块链成长的关键因素有哪些？

医疗保健领域区块链市场的成长受到多种因素的驱动，这些因素源于技术进步、行业优先事项的转变以及对数据透明度和安全性日益增长的需求。首先，从电子健康记录 (EHR) 和远端监控设备到基因组资料库，数位健康数据的爆炸性增长需要强大的防篡改储存、共用和存取管理系统。其次，资料外洩和医疗诈骗的增多，促使医疗机构寻求比传统IT基础设施更安全的替代方案，而区块链提供了即时追踪和加密保护措施，可提高审核和可靠性。此外，以多职业护理协调、远端医疗的扩展和全球供应链为代表的医疗保健服务日益复杂，这要求采用区块链支援的去中心化资料管理方法。例如，製药公司越来越多地采用区块链来确保药品生产和分销的透明度和可追溯性，尤其是在全球供应链中断之后。另一个主要驱动因素是向基于价值观的医疗保健和以患者为中心的模式的转变，这需要透明的数据流和检验的患者治疗结果。创业投资和企业对区块链医疗新兴企业的研发也加速了创新和部署，尤其是在美国、欧洲和亚太等市场。最后，病人的期望也在不断变化，越来越多的个人要求掌控自己的健康资讯及其使用方式，这促使医疗服务提供者和支付方采用赋予病人更多自主权的解决方案。这些因素共同为区块链技术在医疗保健领域的应用创造了肥沃的土壤，使其转变为更安全、更有效率、更基于信任的系统。

部分

网路（专用网路、公用网路）、最终用途（生物製药和医疗设备公司、供应商、付款人）、应用（供应链管理应用、临床试验应用、临床资料交换应用）

受访公司范例（值得关注的36家公司）

  • Accenture Plc
  • Akiri
  • Avaneer Health
  • Blockchain Labs
  • Briya
  • BurstIQ
  • Change Healthcare
  • Chronicled
  • Doc.ai
  • Embleema
  • EncrypGen
  • FarmaTrust
  • Gem
  • Guardtime
  • IBM Corporation
  • iSolve LLC
  • Medicalchain
  • Microsoft Corporation
  • Nebula Genomics
  • Patientory Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP36398

Global Blockchain in Healthcare Market to Reach US$13.0 Billion by 2030

The global market for Blockchain in Healthcare estimated at US$1.2 Billion in the year 2024, is expected to reach US$13.0 Billion by 2030, growing at a CAGR of 49.0% over the analysis period 2024-2030. Private Network, one of the segments analyzed in the report, is expected to record a 51.8% CAGR and reach US$10.4 Billion by the end of the analysis period. Growth in the Public Network segment is estimated at 40.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$312.2 Million While China is Forecast to Grow at 46.2% CAGR

The Blockchain in Healthcare market in the U.S. is estimated at US$312.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 46.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 44.9% and 41.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 33.2% CAGR.

Global Blockchain in Healthcare Market - Key Trends & Drivers Summarized

Why Is Blockchain Emerging as a Foundational Technology in Healthcare Innovation?

Blockchain technology is rapidly being embraced as a transformative force in healthcare, promising to address some of the most persistent challenges in the industry such as data fragmentation, security vulnerabilities, and inefficiencies in administrative processes. At its core, blockchain provides a decentralized, immutable ledger that enables secure and transparent data sharing across diverse healthcare stakeholders. This unique capability is particularly important in an environment where patient records, insurance claims, clinical trials, and supply chain data are typically siloed and difficult to reconcile. By enabling real-time access to tamper-proof information, blockchain enhances data integrity and facilitates interoperability between systems that traditionally have lacked seamless integration. The heightened need for cybersecurity and privacy in handling electronic health records (EHRs) is another major driver, with blockchain offering end-to-end encryption and verifiable access control that exceed current standards. As digital health services grow-driven by telemedicine, wearables, and health apps-blockchain presents a solution for managing the surge in sensitive health data being generated and shared across devices. Moreover, governments and regulatory bodies are increasingly recognizing the technology’s potential, with several pilot programs and public-private partnerships being launched globally to test blockchain-based applications in health record management, drug traceability, and consent handling. As trust and transparency become critical pillars in healthcare transformation, blockchain is positioning itself not merely as an IT enhancement but as a foundational enabler of a new era in healthcare delivery.

How Are Blockchain Applications Evolving Across Different Healthcare Segments?

The scope of blockchain in healthcare is expanding rapidly, with applications emerging across multiple segments including patient data management, pharmaceutical supply chains, clinical trials, insurance, and provider credentialing. In the realm of patient records, blockchain facilitates the creation of longitudinal health records that patients can own, control, and share securely with multiple providers. This is particularly valuable in managing chronic diseases and coordinating care across specialties and geographic regions. In the pharmaceutical industry, blockchain is being deployed to combat counterfeit drugs by enabling end-to-end traceability of medications from manufacturer to pharmacy. Such transparency ensures authenticity, reduces fraud, and enhances drug recall efficiency. Similarly, blockchain is improving the integrity of clinical trials by providing immutable timestamped data for protocols, patient consent, and trial results-ensuring regulatory compliance and minimizing the risk of data manipulation. In insurance, smart contracts are streamlining claims adjudication, automating approvals and payments while reducing fraud and administrative costs. Meanwhile, healthcare organizations are beginning to use blockchain to validate provider credentials and licensure in real-time, speeding up hiring and improving workforce mobility. These applications are not only improving efficiency but are also reshaping how trust is built and maintained across the healthcare ecosystem. As more healthcare entities adopt interoperable blockchain platforms, the technology is evolving from niche use cases to enterprise-wide integration, heralding a more collaborative, patient-centric, and data-secure future.

How Do Regulatory Frameworks and Industry Collaboration Influence Blockchain Adoption?

The adoption of blockchain in healthcare is deeply influenced by regulatory frameworks, cross-sector collaboration, and the establishment of technical standards that enable interoperability and trust. As a highly regulated industry, healthcare must ensure that blockchain implementations comply with strict legal requirements such as HIPAA in the U.S., GDPR in Europe, and other regional data protection laws. These regulations necessitate careful design of blockchain architectures that can support privacy by design, selective data access, and right-to-be-forgotten functionalities-capabilities that challenge the traditionally immutable nature of blockchain. To navigate these complexities, industry consortia such as the Synaptic Health Alliance and the MediLedger Project are emerging, bringing together insurers, providers, technology firms, and regulatory bodies to co-develop blockchain frameworks that meet compliance standards while maximizing innovation. Collaboration is also essential in creating common protocols for data exchange and system interoperability, which remain key barriers to large-scale deployment. Standards development organizations like HL7 and IEEE are working on incorporating blockchain into existing healthcare interoperability frameworks such as FHIR (Fast Healthcare Interoperability Resources). Government funding and sandbox initiatives are further accelerating blockchain experimentation in healthcare, helping mitigate risk and validate ROI. The ability of stakeholders to work collectively-across competitive boundaries-will largely determine how quickly blockchain can move from pilots to widespread adoption. In this context, regulatory clarity, stakeholder alignment, and scalable technical standards are becoming critical enablers that will shape the pace and scope of blockchain integration into mainstream healthcare operations.

What Key Factors Are Driving Growth in the Blockchain in Healthcare Market?

The growth in the blockchain in healthcare market is driven by several factors rooted in technology advancements, shifting industry priorities, and growing demand for data transparency and security. First and foremost, the explosion of digital health data-from EHRs and remote monitoring devices to genomic databases-requires robust, tamper-proof systems for storage, sharing, and access management, a need that blockchain is uniquely positioned to fulfill. Second, the rising incidence of data breaches and healthcare fraud is pushing institutions to seek more secure alternatives to traditional IT infrastructure, with blockchain offering real-time tracking and cryptographic safeguards that enhance auditability and trust. Additionally, the growing complexity of healthcare delivery-marked by multi-provider care coordination, telemedicine expansion, and global supply chains-demands a decentralized approach to data management that blockchain enables. Pharmaceutical companies, for example, are increasingly adopting blockchain to ensure transparency and traceability in drug manufacturing and distribution, especially in the wake of global supply chain disruptions. Another significant driver is the shift toward value-based care and patient-centric models, which require transparent data flows and verifiable patient outcomes-functions that blockchain can support through smart contracts and immutable patient records. Venture capital investment and corporate R&D in blockchain healthcare startups are also accelerating innovation and deployment, particularly in markets such as the U.S., Europe, and Asia-Pacific. Finally, patient expectations are evolving, with more individuals demanding control over their health information and how it is used, prompting providers and payers to adopt solutions that empower patient agency. Together, these factors are creating a fertile environment for blockchain technologies to take root in healthcare, transforming it into a more secure, efficient, and trust-based system.

SCOPE OF STUDY:

The report analyzes the Blockchain in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Network (Private Network, Public Network); End-Use (Biopharma & Medical Device Companies End-Use, Providers End-Use, Payers End-Use); Application (Supply Chain Management Application, Clinical Trials Application, Clinical Data Exchange Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Accenture Plc
  • Akiri
  • Avaneer Health
  • Blockchain Labs
  • Briya
  • BurstIQ
  • Change Healthcare
  • Chronicled
  • Doc.ai
  • Embleema
  • EncrypGen
  • FarmaTrust
  • Gem
  • Guardtime
  • IBM Corporation
  • iSolve LLC
  • Medicalchain
  • Microsoft Corporation
  • Nebula Genomics
  • Patientory Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Blockchain in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Focus on Data Security and Patient Privacy Throws the Spotlight on Blockchain Solutions in Healthcare
    • Rising Incidence of Cyberattacks Spurs Demand for Immutable and Decentralized Record-Keeping Systems
    • Here's How Blockchain Is Reshaping Electronic Health Record Sharing Across Multi-Stakeholder Networks
    • Push for Interoperability and Real-Time Access Fuels Blockchain Adoption in Health Information Exchange
    • Here's the Story: How Smart Contracts Are Streamlining Provider Payments and Clinical Trial Agreements
    • Growth in Digital Health Ecosystems Supports Blockchain-Based Identity and Consent Management Tools
    • Cross-Border Health Data Transfer and Medical Tourism Drive Demand for Blockchain-Enabled Credentialing
    • Public Health and Pandemic Response Platforms Explore Blockchain for Secure and Verified Data Sharing
    • Investment from Tech Giants and Startups Accelerates Innovation in Blockchain Healthcare Infrastructure
    • Lack of Technical Standards, Interoperability, and Industry Alignment Pose Adoption Challenges
    • Blockchain Integration with AI and IoMT Enhances Predictive Healthcare and Remote Monitoring Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blockchain in Healthcare Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blockchain in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Blockchain in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Private Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Private Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Private Network by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Public Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Public Network by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Public Network by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biopharma & Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biopharma & Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Biopharma & Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Supply Chain Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Supply Chain Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Trials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Trials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Clinical Trials Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Data Exchange Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical Data Exchange Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinical Data Exchange Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • CHINA
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Blockchain in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Blockchain in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Blockchain in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Network - Private Network and Public Network - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Blockchain in Healthcare by Network - Private Network and Public Network Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Blockchain in Healthcare by Network - Percentage Breakdown of Value Sales for Private Network and Public Network for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Blockchain in Healthcare by End-Use - Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Blockchain in Healthcare by End-Use - Percentage Breakdown of Value Sales for Biopharma & Medical Device Companies End-Use, Providers End-Use and Payers End-Use for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Blockchain in Healthcare by Application - Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Blockchain in Healthcare by Application - Percentage Breakdown of Value Sales for Supply Chain Management Application, Clinical Trials Application and Clinical Data Exchange Application for the Years 2014, 2025 & 2030

IV. COMPETITION